Abstract
Over the past 25 years, the development of an in vivo model to test for calcific aortic valve disease has been challenging. The understanding of the biology, imaging, and duration of exposure to risk factors, have been the cornerstone for defining the different stages of osteoblast differentiation. The first experimental was high cholesterol-diet rabbit model. The studies published demonstrated apoptosis [1], cell proliferation [2], and atherosclerosis [1, 3–6] along the aortic valve surface. These models all include short time diet experiments to define the early atherosclerotic findings in the valve. The next level of experimentation includes testing the diet for 6 months. This duration of diet provides the time necessary for the valve to mineralize and to calcify.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rajamannan NM, Sangiorgi G, Springett M, Arnold K, Mohacsi T, Spagnoli LG, Edwards WD, Tajik AJ, Schwartz RS. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis. 2001;10:371–4.
Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, Singh RJ, Stone NJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2260–5.
Sarphie TG. Interactions of igg and beta-vldl with aortic valve endothelium from hypercholesterolemic rabbits. Atherosclerosis. 1987;68:199–212.
Sarphie TG. A cytochemical study of the surface properties of aortic and mitral valve endothelium from hypercholesterolemic rabbits. Exp Mol Pathol. 1986;44:281–96.
Sarphie TG. Anionic surface properties of aortic and mitral valve endothelium from New Zealand white rabbits. Am J Anat. 1985;174:145–60.
Sarphie TG. Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits. Atherosclerosis. 1985;54:283–99.
Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML, Osteoporosis-Pseudoglioma Syndrome Collaborative G. Ldl receptor-related protein 5 (lrp5) affects bone accrual and eye development. Cell. 2001;107:513–23.
Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. A mutation in the ldl receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002;70:11–9.
Kim DH, Inagaki Y, Suzuki T, Ioka RX, Yoshioka SZ, Magoori K, Kang MJ, Cho Y, Nakano AZ, Liu Q, Fujino T, Suzuki H, Sasano H, Yamamoto TT. A new low density lipoprotein receptor related protein, lrp5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein e. J Biochem. 1998;124:1072–6.
Willert K, Nusse R. Beta-catenin: a key mediator of wnt signaling. Curr Opin Genet Dev. 1998;8:95–102.
Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of beta-catenin with the transcription factor lef-1. Nature. 1996;382:638–42.
Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor lef-1. Mech Dev. 1996;59:3–10.
Holmen SL, Salic A, Zylstra CR, Kirschner MW, Williams BO. A novel set of wnt-frizzled fusion proteins identifies receptor components that activate beta-catenin-dependent signaling. J Biol Chem. 2002;277:34727–35.
Caverzasio J. [wnt/lrp5, a new regulation osteoblastic pathway involved in reaching peak bone masses]. Rev Med Suisse Romande. 2004;124:81–2.
Kahler RA, Westendorf JJ. Lymphoid enhancer factor-1 and beta-catenin inhibit runx2-dependent transcriptional activation of the osteocalcin promoter. J Biol Chem. 2003;278:11937–44.
Smith E, Frenkel B. Glucocorticoids inhibit the transcriptional activity of lef/tcf in differentiating osteoblasts in a glycogen synthase kinase-3{beta}-dependent and -independent manner. J Biol Chem. 2005;280:2388–94.
Wang HY, Malbon CC. Wnt signaling, ca2+, and cyclic gmp: visualizing frizzled functions. Science. 2003;300:1529–30.
Gregory CA, Perry AS, Reyes E, Conley A, Gunn WG, Prockop DJ. Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem. 2005;280:2309–23.
Yano F, Kugimiya F, Ohba S, Ikeda T, Chikuda H, Ogasawara T, Ogata N, Takato T, Nakamura K, Kawaguchi H, Chung UI. The canonical wnt signaling pathway promotes chondrocyte differentiation in a sox9-dependent manner. Biochem Biophys Res Commun. 2005;333:1300–8.
Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, McConnell JP, Singh RJ, Bonow RO, Spelsberg TC. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart. 2005;91:806–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Rajamannan, N.M., Cicek, M., Hawse, J.R., Spelsberg, T.C., Subramaniam, M. (2014). Experimental Model of Aortic Valve Calcification to Induce Osteoblast Differentiation. In: Rajamannan, N. (eds) Molecular Biology of Valvular Heart Disease. Springer, London. https://doi.org/10.1007/978-1-4471-6350-3_4
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6350-3_4
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6349-7
Online ISBN: 978-1-4471-6350-3
eBook Packages: MedicineMedicine (R0)